Literature DB >> 24018593

Performance characteristics of endoscopic ultrasound in the staging of pancreatic cancer: a meta-analysis.

Haq Nawaz1, Chen Yi Fan, John Kloke, Asif Khalid, Kevin McGrath, Douglas Landsittel, Georgios I Papachristou.   

Abstract

CONTEXT: The optimal approach to pre-operative imaging assessment of pancreatic cancer is unknown.
OBJECTIVE: The aim of this meta-analysis was to assess accuracy and performance characteristics of EUS in determining nodal staging, vascular invasion, and prediction of resectability of pancreatic cancer. A secondary aim was to perform head to head comparison of performance characteristics between EUS and CT for nodal staging, vascular invasion and resectability.
DESIGN: Data from EUS studies were pooled according to bivariate generalized random effects model. Pooled estimates for CT were obtained from studies which performed head to head comparison between EUS and CT. PATIENTS: Patients with pancreatic cancer undergoing pre-operative imaging assessment. INTERVENTION: EUS. MAIN OUTCOME MEASURE: Pooled sensitivity, specificity, positive and negative predictive values of EUS for nodal staging, vascular invasion and resectability.
RESULTS: Forty-nine studies were considered of which 29 met inclusion criteria with a total of 1,330 patients. Pooled summary estimates for EUS-nodal staging were 69% for sensitivity and 81% for specificity. For vascular invasion, sensitivity was 85% and specificity was 91%. The sensitivity and specificity for resectability was 90% and 86%, respectively. CT scan showed lower sensitivity than EUS for nodal staging (24% vs. 58%) and vascular invasion (58% vs. 86%); however, the specificities for nodal staging (88% vs. 85%) and vascular invasion (95% vs. 93%) were comparable in studies where both imaging techniques were performed. The sensitivity and specificity of CT in determining resectability (90% and 69%) was similar to that of EUS (87% and 89%).
CONCLUSIONS: EUS is an accurate pre-operative tool in the assessment of nodal staging, vascular invasion and resectability in patients with pancreatic cancer.

Entities:  

Mesh:

Year:  2013        PMID: 24018593      PMCID: PMC4407641          DOI: 10.6092/1590-8577/1512

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  68 in total

1.  Preoperative assessment of pancreatic malignancy using endoscopic ultrasound.

Authors:  I F Yusoff; R M Mendelson; S E J Edmunds; D Ramsay; G L Cullingford; D R Fletcher; A M J Zimmerman
Journal:  Abdom Imaging       Date:  2003 Jul-Aug

2.  Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma: a meta-analysis.

Authors:  Shandra Bipat; Saffire S K S Phoa; Otto M van Delden; Patrick M M Bossuyt; Dirk J Gouma; Johan S Laméris; Jaap Stoker
Journal:  J Comput Assist Tomogr       Date:  2005 Jul-Aug       Impact factor: 1.826

3.  [Prospective evaluation of the clinical significance of ultrasonography, helical computed tomography, magnetic resonance imaging and endoscopic ultrasonography in the assessment of vascular invasion and lymph node metastasis of pancreatic carcinoma].

Authors:  Yan-Tao Tian; Cheng-Feng Wang; Gui-Qi Wang; Xin-Ming Zhao; Han Ouyang; Yu-Zhi Hao; Yan Chen; Hong-Mei Zhang; Ping Zhao
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2008-09

4.  Radial scanning and linear array endosonography for staging pancreatic cancer: a prospective randomized comparison.

Authors:  F Gress; T Savides; O Cummings; S Sherman; G Lehman; S Zaidi; R Hawes
Journal:  Gastrointest Endosc       Date:  1997-02       Impact factor: 9.427

5.  The clinical utility of endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of pancreatic carcinoma.

Authors:  K J Chang; P Nguyen; R A Erickson; T E Durbin; K D Katz
Journal:  Gastrointest Endosc       Date:  1997-05       Impact factor: 9.427

6.  Comparison of multidetector CT and endoscopic ultrasonography in malignant pancreatic mass lesions.

Authors:  Mahmut Arabul; Funda Karakus; Emrah Alper; Altay Kandemir; Mustafa Celik; Volkan Karakus; Kamil Yucel; Belkis Unsal
Journal:  Hepatogastroenterology       Date:  2012 Jul-Aug

7.  Defining a role for endoscopic ultrasound in staging periampullary tumors.

Authors:  M Shoup; P Hodul; G V Aranha; D Choe; M Olson; J Leya; J Losurdo
Journal:  Am J Surg       Date:  2000-06       Impact factor: 2.565

8.  Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas.

Authors:  Antonio Sa Cunha; Alexandre Rault; Christophe Laurent; Xavier Adhoute; Veronique Vendrely; Geneviève Béllannée; René Brunet; Denis Collet; Bernard Masson
Journal:  J Am Coll Surg       Date:  2005-09       Impact factor: 6.113

Review 9.  Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review.

Authors:  John Dewitt; Benedict M Devereaux; Glen A Lehman; Stuart Sherman; Thomas F Imperiale
Journal:  Clin Gastroenterol Hepatol       Date:  2006-05-03       Impact factor: 11.382

10.  Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography.

Authors:  Antonio Soriano; Antoni Castells; Carmen Ayuso; Juan Ramón Ayuso; Maria Teresa de Caralt; Maria Angels Ginès; Maria Isabel Real; Rosa Gilabert; Llorenç Quintó; Antoni Trilla; Faust Feu; Xavier Montanyà; Laureano Fernández-Cruz; Salvador Navarro
Journal:  Am J Gastroenterol       Date:  2004-03       Impact factor: 10.864

View more
  26 in total

1.  Feasibility and reliability of pancreatic cancer staging using a new confocal non-fluorescent microscopy probe: a double-blind study in rats.

Authors:  Cherif Akladios; Vivian De Ruijter; Sylvana Perretta; Marc Aprahamian; Mihaela Ignat; Veronique Lindner; Gerlinde Averous; Bernard Dallemagne; Jacques Marescaux
Journal:  Surg Endosc       Date:  2016-06-28       Impact factor: 4.584

Review 2.  Diagnosis and staging of pancreatic ductal adenocarcinoma.

Authors:  C Guillén-Ponce; J Blázquez; I González; E de-Madaria; J Montáns; A Carrato
Journal:  Clin Transl Oncol       Date:  2017-06-13       Impact factor: 3.405

Review 3.  [Pancreatic ductal adenocarcinoma].

Authors:  E Gallmeier; T M Gress
Journal:  Internist (Berl)       Date:  2018-08       Impact factor: 0.743

4.  Effect of pretreatment psoas muscle mass on survival for patients with unresectable pancreatic cancer undergoing systemic chemotherapy.

Authors:  Noriko Ishii; Yoshinori Iwata; Hiroki Nishikawa; Hirayuki Enomoto; Nobuhiro Aizawa; Akio Ishii; Yuho Miyamoto; Yukihisa Yuri; Kunihiro Hasegawa; Chikage Nakano; Takashi Nishimura; Kazunori Yoh; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Ryo Takata; Hiroko Iijima; Shuhei Nishiguchi
Journal:  Oncol Lett       Date:  2017-09-15       Impact factor: 2.967

Review 5.  The Role of Endoscopic Ultrasound in Pancreatic Cancer Staging in the Era of Neoadjuvant Therapy and Personalised Medicine.

Authors:  Miguel Bispo; Susana Marques; Ricardo Rio-Tinto; Paulo Fidalgo; Jacques Devière
Journal:  GE Port J Gastroenterol       Date:  2020-09-07

6.  A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases.

Authors:  Satoshi Nishiwada; Masayuki Sho; Jasjit K Banwait; Kensuke Yamamura; Takahiro Akahori; Kota Nakamura; Hideo Baba; Ajay Goel
Journal:  Gastroenterology       Date:  2020-05-04       Impact factor: 22.682

7.  Pancreatic cancer with portal vein invasion diagnosed by endoscopic ultrasound.

Authors:  Augusto P C Carbonari; Juliana Bonfim; Rogerio Colaiacovo; Lucio G B Rossini
Journal:  Endosc Ultrasound       Date:  2015 Apr-Jun       Impact factor: 5.628

Review 8.  From Clinical Standards to Translating Next-Generation Sequencing Research into Patient Care Improvement for Hepatobiliary and Pancreatic Cancers.

Authors:  Ioannis D Kyrochristos; Georgios K Glantzounis; Demosthenes E Ziogas; Ioannis Gizas; Dimitrios Schizas; Efstathios G Lykoudis; Evangelos Felekouras; Anastasios Machairas; Christos Katsios; Theodoros Liakakos; William C Cho; Dimitrios H Roukos
Journal:  Int J Mol Sci       Date:  2017-01-18       Impact factor: 5.923

9.  Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain.

Authors:  M Hidalgo; R Álvarez; J Gallego; C Guillén-Ponce; B Laquente; T Macarulla; A Muñoz; M Salgado; R Vera; J Adeva; I Alés; S Arévalo; J Blázquez; A Calsina; A Carmona; E de Madaria; R Díaz; L Díez; T Fernández; B G de Paredes; M E Gallardo; I González; O Hernando; P Jiménez; A López; C López; F López-Ríos; E Martín; J Martínez; A Martínez; J Montans; R Pazo; J C Plaza; I Peiró; J J Reina; A Sanjuanbenito; R Yaya; Alfredo Carrato
Journal:  Clin Transl Oncol       Date:  2016-12-19       Impact factor: 3.405

10.  The incremental benefit of EUS for identifying unresectable disease among adults with pancreatic adenocarcinoma: A meta-analysis.

Authors:  Paul D James; Zhao Wu Meng; Mei Zhang; Paul J Belletrutti; Rachid Mohamed; William Ghali; Derek J Roberts; Guillaume Martel; Steven J Heitman
Journal:  PLoS One       Date:  2017-03-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.